These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 12482131)

  • 21. Microangiopathic hemolytic anemia (MAHA) as paraneoplastic syndrome in metastasized signet ring cell carcinomas: case reports and review of the literature.
    Arkenau HT; Müssig O; Buhr T; Jend HH; Porschen R
    Z Gastroenterol; 2005 Aug; 43(8):719-22. PubMed ID: 16088769
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Induction chemotherapy with docetaxel, cisplatin, fluorouracil, and leucovorin for squamous cell carcinoma of the head and neck: a phase I/II trial.
    Colevas AD; Busse PM; Norris CM; Fried M; Tishler RB; Poulin M; Fabian RL; Fitzgerald TJ; Dreyfuss A; Peters ES; Adak S; Costello R; Barton JJ; Posner MR
    J Clin Oncol; 1998 Apr; 16(4):1331-9. PubMed ID: 9552034
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Docetaxel-cisplatin combined chemotherapy in Japanese patients with anthracycline-pretreated advanced breast cancer.
    Kariya S; Ogawa Y; Nishioka A; Yoshida S
    Oncol Rep; 2002; 9(6):1345-9. PubMed ID: 12375046
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Concurrent platinum and docetaxel chemotherapy and external radical radiotherapy in patients with invasive transitional cell bladder carcinoma. A preliminary report of tolerance and local control.
    Varveris H; Delakas D; Anezinis P; Haldeopoulos D; Mazonakis M; Damilakis J; Metaxaris G; Chondros N; Mavromanolakis E; Daskalopoulos G; Dimitrakopoulos A; Kranidis A
    Anticancer Res; 1997; 17(6D):4771-80. PubMed ID: 9494605
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Overview of docetaxel (Taxotere)/cisplatin combination in non-small cell lung cancer.
    Le Chevalier T; Bérille J; Zalcberg JR; Millward MJ; Monnier A; Douillard JY; McKeage MJ; James R; Soulas F; Loret C; Bougon N; Bizzari JP
    Semin Oncol; 1999 Jun; 26(3 Suppl 11):13-8. PubMed ID: 10458205
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Docetaxel in the management of advanced non-small cell lung cancer.
    Miller VA
    Semin Oncol; 1998 Jun; 25(3 Suppl 8):15-9. PubMed ID: 9704671
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Amelioration of docetaxel/cisplatin induced polyneuropathy by alpha-lipoic acid.
    Gedlicka C; Kornek GV; Schmid K; Scheithauer W
    Ann Oncol; 2003 Feb; 14(2):339-40. PubMed ID: 12562664
    [No Abstract]   [Full Text] [Related]  

  • 28. Docetaxel: new indication. First-line treatment of non small-cell lung cancer: no advance.
    Prescrire Int; 2005 Feb; 14(75):16-8. PubMed ID: 15751170
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Docetaxel and cisplatin in metastatic urothelial cancer: a phase II study.
    Sengeløv L; Kamby C; Lund B; Engelholm SA
    J Clin Oncol; 1998 Oct; 16(10):3392-7. PubMed ID: 9779718
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Second-line combination chemotherapy with docetaxel for cisplatin-pretreated refractory metastatic esophageal cancer: a preliminary report of initial experience.
    Tanaka T; Fujita H; Sueyoshi S; Tanaka Y; Sasahara H; Mori N; Nagano T; Yamana H; Shirouzu K
    Chemotherapy; 2007; 53(6):449-53. PubMed ID: 17952006
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Phase I trial of docetaxel and cisplatin in previously untreated patients with advanced non-small-cell lung cancer.
    Millward MJ; Zalcberg J; Bishop JF; Webster LK; Zimet A; Rischin D; Toner GC; Laird J; Cosolo W; Urch M; Bruno R; Loret C; James R; Blanc C
    J Clin Oncol; 1997 Feb; 15(2):750-8. PubMed ID: 9053501
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Efficacy and toxicity of a taxotere/cisplatin combination in first line chemotherapy in patients with disseminated ovarian cancer].
    Gorbunova VA; Khokhlova SV; Besova NS; Orel NF; Kuznetsov VV; Bliumenberg AG; Smirnova NB; Chekalova MA; Sinitsyna ME; Poddubnyĭ BK
    Vopr Onkol; 2001; 47(5):1-6. PubMed ID: 11799946
    [No Abstract]   [Full Text] [Related]  

  • 33. Combined effect of docetaxel and cisplatin for non-small cell lung cancer cell lines in vitro.
    Wang H
    Nagoya J Med Sci; 2000 Nov; 63(3-4):129-37. PubMed ID: 11201987
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mediastinal lymph node clearance after docetaxel-cisplatin neoadjuvant chemotherapy is prognostic of survival in patients with stage IIIA pN2 non-small-cell lung cancer: a multicenter phase II trial.
    Betticher DC; Hsu Schmitz SF; Tötsch M; Hansen E; Joss C; von Briel C; Schmid RA; Pless M; Habicht J; Roth AD; Spiliopoulos A; Stahel R; Weder W; Stupp R; Egli F; Furrer M; Honegger H; Wernli M; Cerny T; Ris HB
    J Clin Oncol; 2003 May; 21(9):1752-9. PubMed ID: 12721251
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Phase III randomized trial of docetaxel in combination with cisplatin or carboplatin or vinorelbine plus cisplatin in advanced non--small cell lung cancer: interim analysis.
    Belani C;
    Semin Oncol; 2001 Jun; 28(3 Suppl 9):10-4. PubMed ID: 11441409
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Severe microangiopathic hemolytic anemia as first manifestation of a CUP syndrome. Rapid hematologic remission under polychemotherapy].
    Abdel Samie A; Sandritter B; Theilmann L
    Med Klin (Munich); 2004 Mar; 99(3):148-53. PubMed ID: 15024487
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Docetaxel combination produces 2-year survival advantage in NSCLC patients.
    Oncology (Williston Park); 2001 Dec; 15(12):1559, 1564. PubMed ID: 11780700
    [No Abstract]   [Full Text] [Related]  

  • 38. Phase II Trial of docetaxel and cisplatin combination chemotherapy in patients with squamous cell carcinoma of the head and neck.
    Glisson BS; Murphy BA; Frenette G; Khuri FR; Forastiere AA
    J Clin Oncol; 2002 Mar; 20(6):1593-9. PubMed ID: 11896109
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Phase I and pharmacologic study of docetaxel and cisplatin in patients with advanced solid tumors.
    Pronk LC; Schellens JH; Planting AS; van den Bent MJ; Hilkens PH; van der Burg ME; de Boer-Dennert M; Ma J; Blanc C; Harteveld M; Bruno R; Stoter G; Verweij J
    J Clin Oncol; 1997 Mar; 15(3):1071-9. PubMed ID: 9060547
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Docetaxel (Taxotere) and vinorelbine in the treatment of non-small cell lung cancer.
    Georgoulias V; Kourousis C; Androulakis N; Kakolyris S; Papadakis E; Bouros D; Apostolopoulou F; Georgopoulou T; Agelidou M; Souglakos J; Halkiadakis G; Hatzidaki D
    Semin Oncol; 1997 Aug; 24(4 Suppl 14):S14-9-S14-14. PubMed ID: 9335517
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.